Hims House Ep 48 - Saad Alam (CEO, Hone Health) on Longevity, Testosterone, & Peptides
11 snips
Oct 14, 2025 Saad Alam, Founder and CEO of Hone Health, shares his journey into hormonal health and telehealth. He discusses the innovative services Hone offers, including testosterone therapy and personalized diagnostics. With insights into the future of primary care, he explores the intriguing landscape of peptides and longevity medications. Saad also touches on the effects of social media ad policies on healthcare advertising and expresses optimism about the potential of longevity platforms transforming the industry.
AI Snips
Chapters
Transcript
Episode notes
Founding From Personal Health Crisis
- Saad started Hone Health in March 2020 after a personal health crisis revealed very low testosterone and poor primary care answers. He combined his recovery and his father's preventable illness to build a longevity-focused clinic starting with men's hormones.
Full-Stack Hormone And Longevity Platform
- Hone offers hormone optimization, weight-loss and thyroid meds, and longevity therapies for men and women. They position as a process-driven longevity provider rather than a single-product vendor.
Consider Clomiphene For Endogenous TRT
- Use clomiphene/enclomiphene as an off-label option to stimulate endogenous testosterone via LH signaling when appropriate. Rely on long-term safety and efficacy data before prescribing off-label therapies.